[{"address1": "2 Corporate Drive", "address2": "First Floor", "city": "South San Francisco", "state": "CA", "zip": "94080", "country": "United States", "phone": "650 239 2030", "website": "https://www.sentibio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Senti Biosciences, Inc., a clinical stage biotechnology company, develops cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. Its lead product candidates utilize off-the-shelf healthy adult donor derived natural killer (NK) cells to create CAR-NK cells outfitted with gene circuit technologies in various oncology indications with unmet need. The company's product candidates also include SENTI-202, a logic gated off-the-shelf CAR-NK cell therapy for the treatment of blood cancers and relapsed/refractory hematological malignancies, including acute myeloid leukemia; and SENTI-301A, an off-the-shelf CAR-NK cell therapy for the treatment of solid tumors and hepatocellular carcinoma. In addition, it develops the tumor-associated antigen and protective antigen paired discovery platform to select and validate NOT GATE antigen candidates and identify tumor-associated antigens in cancer cells. Further, its pipeline includes preclinical programs, which comprise a solid tumor cell therapy program; and partnered programs related to gene therapies for tissue-directed targets, as well as partnered programs related to cell therapies for regenerative medicines. The company has a strategic collaboration with Celest Therapeutics (Shanghai) Co. Ltd for the clinical development of SENTI-301A to treat solid tumors. Senti Biosciences, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.", "fullTimeEmployees": 34, "companyOfficers": [{"maxAge": 1, "name": "Dr. Timothy K. Lu M.D., Ph.D.", "age": 43, "title": "Co-Founder, CEO & Director", "yearBorn": 1981, "fiscalYear": 2024, "totalPay": 630788, "exercisedValue": 0, "unexercisedValue": 261713}, {"maxAge": 1, "name": "Dr. James J. Collins Ph.D.", "age": 58, "title": "Scientific Co-Founder, Chairperson of Scientific Advisory Board & Independent Director", "yearBorn": 1966, "fiscalYear": 2024, "totalPay": 43875, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Wilson  Wong Ph.D.", "title": "Scientific Co-Founder & Member of Scientific Advisory Board", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jay  Cross", "age": 53, "title": "Chief Financial Officer", "yearBorn": 1971, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Faraz  Siddiqui", "title": "Senior Vice President of Technical Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Robert H. Cutler J.D.", "age": 56, "title": "Senior VP & Head of Legal Affairs", "yearBorn": 1968, "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Thomas P. Chung", "title": "Vice President of Strategic Finance & Corporate Development", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Dee Olomajeye Dragon", "title": "VP of People & Culture Strategy & Head of Administrative Operations", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 2.11, "open": 2.15, "dayLow": 2.15, "dayHigh": 2.2654, "regularMarketPreviousClose": 2.11, "regularMarketOpen": 2.15, "regularMarketDayLow": 2.15, "regularMarketDayHigh": 2.2654, "payoutRatio": 0.0, "beta": 2.244, "trailingPE": 5.945946, "forwardPE": -2.9333334, "volume": 59908, "regularMarketVolume": 59908, "averageVolume": 204800, "averageVolume10days": 647280, "averageDailyVolume10Day": 647280, "bid": 1.62, "ask": 2.86, "bidSize": 2, "askSize": 2, "marketCap": 57378420, "fiftyTwoWeekLow": 1.52, "fiftyTwoWeekHigh": 16.94, "fiftyDayAverage": 3.1568, "twoHundredDayAverage": 3.369025, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 53601204, "profitMargins": 0.0, "floatShares": 11832491, "sharesOutstanding": 26081100, "sharesShort": 284129, "sharesShortPriorMonth": 155580, "sharesShortPreviousMonthDate": 1747267200, "dateShortInterest": 1749772800, "sharesPercentSharesOut": 0.0109, "heldPercentInsiders": 0.57208, "heldPercentInstitutions": 0.28209, "shortRatio": 5.01, "shortPercentOfFloat": 0.011, "impliedSharesOutstanding": 26081100, "bookValue": 1.456, "priceToBook": 1.5109891, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1743379200, "netIncomeToCommon": -57313000, "trailingEps": 0.37, "forwardEps": -0.75, "lastSplitFactor": "1:10", "lastSplitDate": 1721260800, "enterpriseToEbitda": -1.069, "52WeekChange": -0.45897436, "SandP52WeekChange": 0.12632763, "quoteType": "EQUITY", "currentPrice": 2.2, "targetHighPrice": 15.0, "targetLowPrice": 12.0, "targetMeanPrice": 13.5, "targetMedianPrice": 13.5, "recommendationKey": "none", "numberOfAnalystOpinions": 2, "totalCash": 33875000, "totalCashPerShare": 1.299, "ebitda": -50163000, "totalDebt": 32445000, "quickRatio": 3.365, "currentRatio": 4.215, "debtToEquity": 85.7, "returnOnAssets": -0.36455002, "returnOnEquity": -1.16635, "grossProfits": -34858000, "freeCashflow": -5134375, "operatingCashflow": -43765000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "SNTI", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "firstTradeDateMilliseconds": 1622035800000, "corporateActions": [], "regularMarketTime": 1751389795, "exchange": "NCM", "messageBoardId": "finmb_538838857", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": 4.2654104, "regularMarketPrice": 2.2, "shortName": "Senti Biosciences, Inc.", "longName": "Senti Biosciences, Inc.", "earningsTimestamp": 1746563700, "earningsTimestampStart": 1755115260, "earningsTimestampEnd": 1755547260, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": 0.37, "epsForward": -0.75, "epsCurrentYear": -3.7, "priceEpsCurrentYear": -0.5945946, "fiftyDayAverageChange": -0.9568, "fiftyDayAverageChangePercent": -0.30309173, "twoHundredDayAverageChange": -1.169025, "twoHundredDayAverageChangePercent": -0.34699208, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "cryptoTradeable": false, "hasPrePostMarketData": true, "regularMarketChange": 0.09000015, "regularMarketDayRange": "2.15 - 2.2654", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 204800, "fiftyTwoWeekLowChange": 0.68000007, "fiftyTwoWeekLowChangePercent": 0.44736847, "fiftyTwoWeekRange": "1.52 - 16.94", "fiftyTwoWeekHighChange": -14.740001, "fiftyTwoWeekHighChangePercent": -0.8701299, "fiftyTwoWeekChangePercent": -45.897438, "marketState": "REGULAR", "displayName": "Senti Biosciences", "trailingPegRatio": null, "__fetch_time": "2025-07-01"}]